Belgium· BE-AMP-SAM663589-00

Icatibant Hikma 30 mg

A icatibant product containing icatibant acetate, registered in Belgium by Hikma Farmacêutica. The same ATC class is registered in 15 of our 19 countries.

ATC B06AC02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about icatibant acetateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Icatibant is registered in 15 of 19 countries.

Countries holding a registration under ATC B06AC02 (icatibant), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search icatibant products by name

Icatibant · ATC B06AC02

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Icatibant Acetate
Manufacturer: Hikma Farmacêutica
Country: Belgium (BE)
ATC code: B06AC02
ATC class: Icatibant
Defined daily dose: 30 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for icatibant.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check icatibant against other medicines How interaction checks work

Icatibant · interactions on record

10 records

10 moderate

Most severe, free to view

CaptoprilC09AA01moderate
EnalaprilC09AA02moderate
LisinoprilC09AA03moderate
PerindoprilC09AA04moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Icatibant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All icatibant products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Icatibant Hikma, Icatibant Ratiopharm®
Bulgaria · Icatibant Sandoz
Czechia · Icatibant Fresenius, Icatibant Universal Farma
Germany · Icatibant Aliud Pharma Gmbh, Icatibant Amarox
Denmark · Icatibant "viatris", Icatibant Adalvo
Estonia · Icatibant Auxilia, Icatibant Fresenius
Spain · Icatibanto Cipla, Icatibanto Exeltis
Finland · Icatibant Avansor, Icatibant Glenmark
France · Icatibant Amarox, Icatibant Fresenius
United Kingdom (Northern Ireland) · Icatibant Amarox, Icatibant Fresenius Kabi Limited
Croatia · Ikatibant Alpha-Medical, Ikatibant Fresenius
Hungary · Icatibant Fresenius, Icatibant Stada
Iceland · Firazyr, Icatibant Accord
Italy · Icatibant, Icatibant Amarox
Liechtenstein · Firazyr, Icatibant Accord
Lithuania · Icatibant Fresenius, Idanuz
Latvia · Idanuz
Malta · Icatibant Newbury, Idisan
Netherlands · Icatibant Ethypharm, Icatibant Glenmark
Norway · Firazyr, Icatibant
Poland · Icatibant Universal Farma, Idanuz
Portugal · Icatibant Fresenius, Icatibant Hikma Farmacêutica (Portugal) S.A.
Romania · Icatibant Stada, Icatibant Universal Farma
Sweden · Icatibant Avansor, Icatibant Glenmark
Slovakia · Icatibant Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d9b12761-e026-4de1-b53f-1dcb9141d6e3
GET /v1/drugs/d9b12761-e026-4de1-b53f-1dcb9141d6e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Icatibant Hikma 30 mg",
  "name_fr": "Icatibant Hikma 30 mg",
  "name_nl": "Icatibant Hikma 30 mg",
  "amp_code": "SAM663589-00",
  "strengths": [
    "31.4000",
    "31.4000",
    "30.0000",
    "30.0000",
    "22.4000",
    "1.9000"
  ],
  "pack_count": 2,
  "substances": [
    "Icatibant Acetate",
    "Icatibant",
    "Sodium Chloride",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Icatibant",
  "authorisation_numbers": [
    "BE663589"
  ]
}

API reference MCP server Plans

See everything about icatibant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console